TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT03247725

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: pain app
Description: Pain Monitor app has been developed by a multidisciplinary pain expert panel, including physicians, psychologists, and nurses. Content has been validated in a previous study and usability has been shown to be excellent.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: pain app
Description: Pain Monitor app has been developed by a multidisciplinary pain expert panel, including physicians, psychologists, and nurses. Content has been validated in a previous study and usability has been shown to be excellent.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Treatment as usual (medical)
Description: Patients will be offered the usual treatment for their pain, which is not changed by study participation

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Treatment as usual (medical)
Description: Patients will be offered the usual treatment for their pain, which is not changed by study participation

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Treatment as usual (medical)
Description: Patients will be offered the usual treatment for their pain, which is not changed by study participation
Study: NCT02593656

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: High Protein
Description: Protein-pacing throughout the day and exercise training for 12 weeks

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Normal Protein
Description: Normal protein intake throughout the day and exercise training for 12 weeks
Study: NCT05373693

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Single vision lens
Description: Wear single vision lens

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: +2D PDL
Description: Wear Peripheral defocus lense with +2D

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: +3D PDL
Description: Wear Peripheral defocus lense with +3D

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: +4D PDL
Description: Wear Peripheral defocus lense with +4D
Study: NCT01292083

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: azacitidine
Description: Given IV

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: laboratory biomarker analysis
Description: Correlative studies
Study: NCT00963924

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Cognitive Remediation
Description: 40 one-hour daily sessions of cognitive remediation (Brain Fitness Program) over eight weeks.
Study: NCT00446095

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: fostamatinib
Description: 200 mg PO BID
Study: NCT02262988

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Total knee replacement
Description: Total knee replacement (TKA)
Study: NCT00625859

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bupropion
Description: Bupropion will be available as sustained release film-coated tablets with a dose of 150 milligrams administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bupropion
Description: Bupropion will be available as sustained release film-coated tablets with a dose of 150 milligrams administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bupropion
Description: Bupropion will be available as sustained release film-coated tablets with a dose of 150 milligrams administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bupropion
Description: Bupropion will be available as sustained release film-coated tablets with a dose of 150 milligrams administered orally.
Study: NCT00625859

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo tablets will be given to subjects.
Study: NCT02262988

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Total knee replacement
Description: Total knee replacement (TKA)

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Total knee replacement
Description: Total knee replacement (TKA)
Study: NCT04389788

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: carboxy therapy
Description: 6 sessions of carboxy therapy every 2 weeks

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Dermapen with topical glutathione
Description: 6 sessions of Dermapen microneedling with topical glutathione every 2 weeks
Study: NCT01292083

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: immunohistochemistry staining method
Description: Correlative studies

Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: polymerase chain reaction
Description: Correlative studies

Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: western blotting
Description: Correlative studies

Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: nucleic acid sequencing
Description: Correlative studies

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: therapeutic conventional surgery
Description: Undergo definitive breast surgery
Study: NCT00625859

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo tablets will be given to subjects.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo tablets will be given to subjects.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo tablets will be given to subjects.
Study: NCT03885544

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Controlled Lacto-ovo vegetarian diet
Description: Subjects will be randomized and assigned into an intervention to consume the controlled lacto-ovo vegetarian (LOV) diet for 3 weeks. All foods will be provided to subjects during the intervention. Each subject's energy requirement will be estimated using sex-specific equations published by the Institute of Medicine for weight maintenance during the intervention.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Controlled Unprocessed red meat diet
Description: The unprocessed red meat diet will be the same as the LOV diet except that one 3-ounce portion of unprocessed red meat per day, 7 days per week (21 oz/wk) will be included. The unprocessed red meat will include beef tenderloin and pork loin. All foods will be provided to subjects during the intervention.
Study: NCT00625859

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo tablets will be given to subjects.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo tablets will be given to subjects.
Study: NCT04184531

Intervention type: OTHER
Intervention: Medical Data Collect
Description: It is a retrospective clinical study and we will collect only the medical data registered in our hospital software
Study: NCT03605797

Intervention type: OTHER
Intervention: follow up of cases fixed by posterior tension band plate
Description: Follow up of the reduction and functional outcome evaluation using the Majeed functional outcome score
Study: NCT01813669

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Integrative Coping Group
Description: The proposed 12-week intervention will integrate yoga-based skills with cognitive-behavioral principles. The development of this program was based on existing and empirically-validated cognitive-behavioral interventions for youth (i.e., Coping Cat and Cat Project; Kendall et al.) and therapeutic yoga interventions (e.g., Galantino et al., 2008 for review). The intervention will be broken down into four three-week modules, which address the following:~Module 1: Introduction to group and awareness of body Module 2: Awareness of emotion and developing an understanding of the mind-body connection Module 3: Focus on cognitive process Module 4: Experiential practice and therapeutic discussions
Study: NCT04199299

Intervention type: DEVICE
Intervention: Heart rate and respiration rate sensors
Description: The use of sensors to monitor physiological variables (e.g. heart rate, sleep). The design is a before-and-after comparison with respect to whether the use of sensors has changed the caregivers' practice and their (perceived) understanding of the participant. The frequency of participants' self harm or aggressive behavior after as compared to before the introduction of pulse- and respiration monitors will also be charted.
Study: NCT03822676

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Prophylactic pancreatic stent
Description: Prophylactic pancreatic stent before segmental pancreatic surgery
Study: NCT00837655

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sevelamer
Description: sevelamer tablets, 800 mg (Renagel(r), Genzyme Inc). The initial daily dose of sevelamer will be 2400 mg (800 mg x 3). After the first week of treatment the dose will be increased to 4800 mg. If treatment with sevelamer is well tolerated and if a phosphate concentration of \<1.8 mmol/l is not obtained, the dose may be increased further. The maximum daily dose of sevelamer will be 9600 mg. If a patient experiences side effects, the dose of sevelamer will be reduced to the highest acceptable dose, and, if a phosphate concentration of \<1.8 mmol/l is not obtained, the treatment will be supplemented with calcium carbonate in a dose tolerated by the patient.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Calcium carbonate
Description: Calcium carbonate tablets, 250 mg (Kalcidon, Abigo AB). Calcium carbonate will be prescribed at the dose given prior to the washout period. The dose will be adjusted weekly to obtain a serum phosphate concentration \<1.8 mmol/l.
Study: NCT01888796

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Linagliptin

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Study: NCT01908361

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Unilateral Hybrid (InMotion3 plus CIT) Intervention
Description: During the 3-week InMotion3 period, participants will receive 5 minutes of muscle tone normalization preparation and passive range of motion, then 85 minutes of training using the InMotion3 robot. The participants will practice about 5 to 8 minutes of passive, 30 to 35 minutes of assisted-active, and 5 to 8 minutes of active motions in wrist and forearm, respectively.~During the 3-week CIT period, participants will receive intensive training of the affected UL in functional tasks with behavioral shaping for 1.5 hours/weekday and will be asked to wear a mitt to restrict the unaffected UL for 6 hours daily. The shaping techniques will involve individualized task selection, graded task difficulty, verbal feedback, prompting, physical assistance with movements, and modeling. Caregivers will use daily logs to document hours of mitt wearing outside the one-on-one intervention sessions.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Bilateral Hybrid (BMT plus BAT) Intervention
Description: During the 3-week BMT period, patients will play a simple computer game (e.g., picking up apples) that tracks patient movements to provide instant visual feedback. The therapist will also provide verbal feedback. In each training session, the patient will practice 600 to 800 repetitions of passive-passive mode for 15 minutes, 600 to 800 repetitions of active-passive mode for 15 to 20 minutes, and 150 to 200 repetitions of active-active mode for 5 minutes, respectively, for the forearm pronation-supination and the wrist flexion-extension.~During the 3-week BAT period, participants will receive training in tasks focusing on bilateral symmetric or alternating movements of both ULs, such as lifting two cups, picking up two pegs, grasping and releasing two towels, and wiping the table with both hands.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Rehabilitation
Description: Participants in CR group will receive therapist-mediated functional tasks training based on neurodevelopmental techniques with emphasis on functional tasks and muscle strengthening that will involve (1) active/passive range of motions, abnormal muscle tone/reflex inhibition techniques (such as stretching and/or weight bearing), and strengthening of affected arm for 15 to 20 minutes, (2) functional tasks for training fine motor or manual dexterity for 20 minutes, and (3) activities of daily living or functional tasks involving gross motor activities, coordination tasks, transition, mobility, and posture/balance for 15 to 20 minutes. The activities will be individualized according to the level of impairment and the needs of the patients.
Study: NCT03885544

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Controlled processed red meat diet
Description: The processed red meat diet will be the same as the LOV diet except that one 3-ounce portion of processed red meat per day, 7 days per week (21 oz/wk) will be included. The processed red meat will include a variety of beef and pork luncheon meats with different methods of preservation. All foods will be provided to subjects during the intervention.
Study: NCT02054208

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: human umbilical cord blood derived mesenchymal stem cells
Description: Low dose: 1 x 10\^7cells/2mL 3 repeated intraventricular administrations via an Ommaya Reservoir at 4 week intervals~High dose: 3 x 10\^7cells/2mL 3 repeated intraventricular administrations via an Ommaya Reservoir at 4 week intervals

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: human umbilical cord blood derived mesenchymal stem cells
Description: Low dose: 1 x 10\^7cells/2mL 3 repeated intraventricular administrations via an Ommaya Reservoir at 4 week intervals~High dose: 3 x 10\^7cells/2mL 3 repeated intraventricular administrations via an Ommaya Reservoir at 4 week intervals

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Normal saline 2mL
Description: Intraventricular administrations of 2mL Normal Saline at 4 week intervals via an Ommaya Reservoir, for a total of 3 administrations
Study: NCT03692871

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: V114
Description: V114 pneumococcal capsular polysaccharide serotypes 1, 3, 4, 5, 6A, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F, 33F (2 mcg each), and serotype 6B (4 mcg) in each 0.5 mL dose
Study: NCT03778684

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Body mass index
Description: Weight and height will be measured with subjects in a standing position wearing light clothes and no shoes.

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Body mass index
Description: Weight and height will be measured with subjects in a standing position wearing light clothes and no shoes.
Study: NCT01635348

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: motor skill gait exercise
Description: The motor skill gait exercise is a task-oriented motor sequence learning approach to exercise to improve walking. The approach involves goal-directed stepping and walking patterns to facilitate use of the appropriate muscles at the appropriate timing relative to body position during gait through the task performance. Treadmill-assisted walking in brief intervals of small increased speed walking interspersed with usual walking speed are performed to induce the automatic rhythm and timing of gait. The exercise sessions are about 60 minutes, 2-3 times a week for 12 weeks or a total of 30-36 sessions.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: aerobic gait intervention
Description: The aerobic gait intervention approach involves treadmill and overground walking with the gradual increases in the distance walked and speed of walking. The exercise approach provides walking practice, including on the treadmill to facilitate the timing of stepping during gait, while also facilitating a fitness or conditioning response, and endurance for walking activities. The exercise sessions are about 60 minutes, 2-3 times weekly for 12 weeks, or about 30-36 sessions.
Study: NCT01433302

Intervention type: PROCEDURE
Intervention: Punch Biopsy
Description: 5 mm punch biopsy specimens from the affected, lymphedematous limb will be obtained just prior to lymphatico-venular bypass and six (6) months after lymphatico-venular bypass. Punch biopsies will be obtained from the radial (lateral) aspect of the upper arm approximately 10cm above the olecranon process. Biopsy specimens will be collected from the contralateral (normal) arm at the exact same location.
Study: NCT00487474

Intervention type: DEVICE
Intervention: DL6049 (injectable poly-L-lactic acid)
Description: Subjects will be treated with SCULPTRA® every 4-6 weeks in accordance with SCULPTRA® package insert
Study: NCT01545973

Intervention type: OTHER
Intervention: Skin Moistening, Skin Denuding
Description: Application of normal saline to skin and Tape stripping of the superficial skin
Study: NCT02526108

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: HIFT
Description: Workout alternates short periods of intense exercise using varied, multiple-joint movements, with less-intense active recovery periods. Workout sessions will be led by a trained instructor.
Study: NCT04167072

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Stent removal
Description: This is a procedural intervention in which the stent will be removed via endoscopy.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Stent removal
Description: This is a procedural intervention in which the stent will be removed via endoscopy.
Study: NCT02990507

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: AVEED: Arm rotation, video display
Description: Participants rotate arm cranks for 5 minutes then rest for 5 minutes.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: AVEED: Arm rotation, without video display
Description: Participants rotate arm cranks for 5 minutes then rest for 5 minutes.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: AVEED: Leg rotation, arm-energy input, video display
Description: Participants rotate leg cranks for 5 minutes then rest for 5 minutes.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: AVEED: Leg rotation, arm-energy input, without video display
Description: Participants rotate leg cranks for 5 minutes then rest for 5 minutes.
Study: NCT04318236

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: HERMES (Online Self-Help Intervention based on problem-solving therapy)
Description: The Online Self-Help Intervention is an online program based on the problem-solving therapy (an evidence based approach of psychotherapy). All participants will receive the exact same intervention.~However, what will be experimentally varied are the four listed interventions.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: HERMES (Online Self-Help Intervention based on problem-solving therapy)
Description: The Online Self-Help Intervention is an online program based on the problem-solving therapy (an evidence based approach of psychotherapy). All participants will receive the exact same intervention.~However, what will be experimentally varied are the four listed interventions.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: HERMES (Online Self-Help Intervention based on problem-solving therapy)
Description: The Online Self-Help Intervention is an online program based on the problem-solving therapy (an evidence based approach of psychotherapy). All participants will receive the exact same intervention.~However, what will be experimentally varied are the four listed interventions.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: HERMES (Online Self-Help Intervention based on problem-solving therapy)
Description: The Online Self-Help Intervention is an online program based on the problem-solving therapy (an evidence based approach of psychotherapy). All participants will receive the exact same intervention.~However, what will be experimentally varied are the four listed interventions.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: HERMES (Online Self-Help Intervention based on problem-solving therapy)
Description: The Online Self-Help Intervention is an online program based on the problem-solving therapy (an evidence based approach of psychotherapy). All participants will receive the exact same intervention.~However, what will be experimentally varied are the four listed interventions.
Study: NCT04533230

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Educational intervention with prescription feedback
Description: Educational intervention and targeted feedback on prescription of benzodiazepines and benzodiazepine-like hypnotics

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Information on treatment guidelines
Description: Written information on treatment guidelines.
Study: NCT04318236

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: HERMES (Online Self-Help Intervention based on problem-solving therapy)
Description: The Online Self-Help Intervention is an online program based on the problem-solving therapy (an evidence based approach of psychotherapy). All participants will receive the exact same intervention.~However, what will be experimentally varied are the four listed interventions.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: HERMES (Online Self-Help Intervention based on problem-solving therapy)
Description: The Online Self-Help Intervention is an online program based on the problem-solving therapy (an evidence based approach of psychotherapy). All participants will receive the exact same intervention.~However, what will be experimentally varied are the four listed interventions.
Study: NCT00005976

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: carboplatin

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: carboplatin

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: carboplatin

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: pyrazoloacridine
Study: NCT03692871

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Prevnar 13™
Description: Prevnar 13™ pneumococcal capsular polysaccharide serotypes 1, 3, 4, 5, 6A, 7F, 9V, 14, 18C, 19A, 19F, 23F (2.2 mcg each) and 6B (4.4 mcg) in each 0.5 ml dose
Study: NCT03658603

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: thoracodorsal artery perforator flap
Description: fascio-cutaneous flap used in cases of trauma or burns

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: latissimus dorsi flap
Description: musculo-cutaneous flap used in cases of trauma or burns
Study: NCT02833948

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Acetylsalicylic acid
Description: Drug: Acetylsalicylic acid:~75 - 100 mg OD (for first 90 days only in arm 1)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid
Description: Drug: Acetylsalicylic acid:~75 - 100 mg OD (for first 90 days only in arm 1)
Study: NCT00005976

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: pyrazoloacridine
Study: NCT01153295

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Clinical diagnosis based on symptom criteria
Description: The diagnosis is based on ROME III criteria, abscence of danger signals and FBC, CRP

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Diagnosis of exclusion
Description: The diagnosis is based on normal investigations involving endoscopy with biopsy, stool for ova and parasites, FBC, CRP, TSH, Ca, ALT, alanine aminotransferase; alkaline phosphatase, serum bilirubin, Screening for lactose and celiac sprue